IRIS UniCatt

Basile, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.931
AS - Asia 2.209
EU - Europa 1.987
SA - Sud America 484
AF - Africa 63
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.825
SG - Singapore 1.118
CN - Cina 550
SE - Svezia 516
BR - Brasile 410
IT - Italia 350
DE - Germania 263
FR - Francia 151
PL - Polonia 136
GB - Regno Unito 125
IE - Irlanda 125
VN - Vietnam 102
IN - India 100
ID - Indonesia 79
FI - Finlandia 74
RU - Federazione Russa 60
CA - Canada 49
MX - Messico 44
BD - Bangladesh 39
JP - Giappone 36
HK - Hong Kong 34
UA - Ucraina 33
TR - Turchia 29
KR - Corea 28
NL - Olanda 25
ZA - Sudafrica 24
AR - Argentina 21
BE - Belgio 21
ES - Italia 21
IQ - Iraq 16
AT - Austria 14
CZ - Repubblica Ceca 13
CO - Colombia 10
MA - Marocco 10
AU - Australia 9
EC - Ecuador 9
IR - Iran 9
LT - Lituania 9
VE - Venezuela 9
CL - Cile 8
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
CI - Costa d'Avorio 7
KE - Kenya 7
PE - Perù 7
PT - Portogallo 7
BG - Bulgaria 6
BY - Bielorussia 6
DK - Danimarca 6
GR - Grecia 6
JO - Giordania 6
PK - Pakistan 6
TN - Tunisia 6
UZ - Uzbekistan 6
LB - Libano 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
DZ - Algeria 4
JM - Giamaica 4
KZ - Kazakistan 4
MY - Malesia 4
RO - Romania 4
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
PH - Filippine 3
AL - Albania 2
AZ - Azerbaigian 2
EG - Egitto 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
LV - Lettonia 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PW - Palau 1
Totale 7.690
Salva come PNG Salva come JPEG
Città #
Singapore 576
Chandler 492
Ashburn 367
New York 159
Beijing 126
Dublin 124
Warsaw 122
Dallas 92
Los Angeles 90
Rome 80
Hefei 77
Jakarta 73
San Mateo 62
The Dalles 58
Frankfurt am Main 54
Boston 53
Fairfield 52
Munich 51
Helsinki 47
São Paulo 47
North Bergen 46
Wilmington 46
Milan 43
Marseille 42
Princeton 42
Moscow 38
Houston 36
Ho Chi Minh City 34
Tokyo 33
Hong Kong 32
Ann Arbor 30
Nanjing 30
Seattle 30
Jacksonville 29
Cattolica 28
Boardman 27
Hanoi 27
Hyderabad 24
London 24
Seoul 24
Atlanta 22
Kent 22
Woodbridge 22
Bremen 21
Dearborn 21
Orem 21
Chicago 20
Nuremberg 20
Redwood City 20
Brooklyn 18
Poplar 18
Johannesburg 17
Mexico City 17
Brussels 16
Montreal 16
Chennai 15
Denver 15
Stockholm 15
Toronto 15
Bologna 14
Castelnuovo di Val di Cecina 14
Falls Church 14
Phoenix 14
Santa Clara 14
Rio de Janeiro 13
San Francisco 13
Hebei 12
Norwalk 12
Tianjin 12
Amsterdam 11
Buffalo 11
Querétaro 11
Shenyang 11
Bexley 10
Edinburgh 10
Falkenstein 10
Lancaster 10
Lappeenranta 10
Paris 10
Turku 10
Cambridge 9
Manchester 9
Nanchang 9
Roubaix 9
Baghdad 8
Belo Horizonte 8
Brno 8
Curitiba 8
Düsseldorf 8
Guangzhou 8
Izmir 8
Leawood 8
Wroclaw 8
Abidjan 7
Auckland 7
Augusta 7
Nairobi 7
Salt Lake City 7
Amman 6
Ankara 6
Totale 4.219
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 321
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 152
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 151
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 147
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 146
Evaluation of screening method for Bence Jones protein analysis 139
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 139
Immunological role of IgG subclasses 139
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 137
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 133
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 131
Overview of immune abnormalities in lysosomal storage disorders 129
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 125
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 122
Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport 121
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 120
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 119
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 118
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 117
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 117
Immunological role of IgG subclasses 116
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 116
Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection 115
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 114
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 111
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 108
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 108
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 107
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 105
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 105
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 101
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 101
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 101
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 100
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 100
SARS-CoV-2 was already circulating in Italy, in early December 2019 98
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity 98
The Laboratory Role in anti-TNF Biological Therapy Era 97
Anti-nuclear antibody detection in cryoprecipitates: Distinctive patterns in hepatitis C virus-infected patients 96
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 94
Antenna-enhanced mid-infrared detection of extracellular vesicles derived from human cancer cell cultures 93
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 93
Heavy chain disease: Our experience 93
IgG cryoglobulinemia 93
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 93
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 92
Cryoglobulins: putative effectors of adaptive immune response 90
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 90
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 88
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 88
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 88
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 88
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 87
Serum free light chain quantitative assays: Dilemma of a biomarker 86
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 85
COVID-19, adaptative immune response and metabolic-associated liver disease 84
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 82
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 79
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 77
Free light chains and autoimmunity 77
The dark side of current analytic methods for Bence Jones Proteinuria 76
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 74
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 74
Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease 73
Type 2 cytokines and scleroderma interstitial lung disease 71
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 63
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 62
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 62
Calprotectin: two sides of the same coin 60
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 57
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 56
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 55
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 55
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 54
SCREENING FOR THE IDENTIFICATION OF AUTOIMMUNE OR LYMPHOPROLIFERATIVE ONSET IN PATIENTS NAiVE TO HCV ANTIVIRAL TREATMENT 49
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 42
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 39
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 28
Post-pandemic drug and alcohol-related road accidents analysis in Central Italy area 16
Totale 7.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 11 8 6 18 17 70 42
2021/2022492 23 11 5 72 38 18 12 76 24 22 80 111
2022/20231.395 204 179 90 212 89 151 84 121 148 20 73 24
2023/2024839 35 194 12 85 26 161 67 34 6 43 72 104
2024/20251.729 60 50 118 84 154 95 40 97 248 156 360 267
2025/20262.549 547 121 309 587 818 167 0 0 0 0 0 0
Totale 7.840